trial

Adult Oxytocin Study

NCTId NCT02577575
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Early Phase 1 · Completed
Enrollment 120 (actual)
Sponsored by University of California Riverside at C.I. Trials, Inc.-Inland Empire
Primary completion 2015-11
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Early Phase 1
Status
Completed
Enrollment
120 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Double
Start
2010-08
Primary completion
2015-11
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Oxytocin

Sponsors

University of California Riverside at C.I. Trials, Inc.-Inland EmpireLead Sponsor
San Francisco Veterans Affairs Medical CenterCollaborator

Investigators

1
Joshua D Woolley, MD/PhDPrincipal Investigator

Sites

2 total
San Francisco, United StatesSan Francisco, United States

Facts & assertions

4 sourced
Enrollment
120
Phase
EARLY_PHASE1
Primary Completion Date
2015-11
Status
COMPLETED
relationships
The graph out of here
drug
Oxytocin
drug
lead_sponsor
University of California Riverside at C.I. Trials, Inc.-Inland Empire
company
collaborator
San Francisco Veterans Affairs Medical Center
company
indication
Schizophrenia
indication
Schizophrenia
indication
Social Cognition
indication
investigator
Joshua D Woolley, MD/PhD
person